Q1 2025 Vext Science Inc Earnings Call Transcript
Key Points
- Vext Science Inc (VEXTF) reported a significant revenue increase to $11.6 million in Q1 2025, driven by strong performance in the Ohio market.
- The company achieved a robust operating cash flow of $3.1 million, nearly matching its entire operating cash flow for 2024.
- Vext's cash flow margin exceeded 26%, placing it among the top cash flow producers across US public multi-state cannabis operators.
- The company's retail-first strategy is yielding strong unit economics, with consolidated retail sales in Ohio growing by 7% in Q1 2025.
- Vext completed the acquisition of two dispensaries from Big Perm, doubling its Ohio retail footprint to four locations, with plans to expand further.
- The Arizona market remains pressured, with total sales down 13% year-over-year, impacting Vext's performance in the state.
- Pricing compression in the Ohio adult-use market is creating challenges, requiring operators to remain disciplined on margins.
- Vext's gross margins have been volatile, with lower margins reported in Q1 2025 compared to previous quarters.
- The company faces uncertainties regarding the final adult-use rules in Ohio, which could impact future operations.
- Vext is experiencing pricing pressures in the wholesale market, which could affect profitability if not managed carefully.
Thank you for standing by. This is the conference operator. Welcome to the Vext Science first-quarter 2025 financial results conference call. (Operator Instructions) The conference is being recorded. (Operator Instructions)
I would now like to turn the conference over to [Priam Chakraborty]. Please go ahead.
Thanks, operator. Good morning, everyone, and thank you for joining us today. Vext's first-quarter 2025 financial results were released earlier this morning. The press release, financial statements, and MD&A are available on SEDAR+ as well as on the Vext website at vextscience.com.
We would like to remind listeners that portions of today's discussion include forward-looking statements and that forward-looking statements are included in today's filing. There can be no assurance that these forward-looking statements will prove to be accurate or that management's expectations or estimates of future developments, circumstances, or results contained therein will materialize.
Risks and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
